Cargando…

Validation strategies for antibodies targeting modified ribonucleotides

Chemical modifications are found on almost all RNAs and affect their coding and noncoding functions. The identification of m(6)A on mRNA and its important role in gene regulation stimulated the field to investigate whether additional modifications are present on mRNAs. Indeed, modifications includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Weichmann, Franziska, Hett, Robert, Schepers, Aloys, Ito-Kureha, Taku, Flatley, Andrew, Slama, Kaouthar, Hastert, Florian D., Angstman, Nicholas B., Cardoso, M. Cristina, König, Julian, Hüttelmaier, Stefan, Dieterich, Christoph, Canzar, Stefan, Helm, Mark, Heissmeyer, Vigo, Feederle, Regina, Meister, Gunter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491328/
https://www.ncbi.nlm.nih.gov/pubmed/32636310
http://dx.doi.org/10.1261/rna.076026.120
_version_ 1783582200882528256
author Weichmann, Franziska
Hett, Robert
Schepers, Aloys
Ito-Kureha, Taku
Flatley, Andrew
Slama, Kaouthar
Hastert, Florian D.
Angstman, Nicholas B.
Cardoso, M. Cristina
König, Julian
Hüttelmaier, Stefan
Dieterich, Christoph
Canzar, Stefan
Helm, Mark
Heissmeyer, Vigo
Feederle, Regina
Meister, Gunter
author_facet Weichmann, Franziska
Hett, Robert
Schepers, Aloys
Ito-Kureha, Taku
Flatley, Andrew
Slama, Kaouthar
Hastert, Florian D.
Angstman, Nicholas B.
Cardoso, M. Cristina
König, Julian
Hüttelmaier, Stefan
Dieterich, Christoph
Canzar, Stefan
Helm, Mark
Heissmeyer, Vigo
Feederle, Regina
Meister, Gunter
author_sort Weichmann, Franziska
collection PubMed
description Chemical modifications are found on almost all RNAs and affect their coding and noncoding functions. The identification of m(6)A on mRNA and its important role in gene regulation stimulated the field to investigate whether additional modifications are present on mRNAs. Indeed, modifications including m(1)A, m(5)C, m(7)G, 2′-OMe, and Ψ were detected. However, since their abundances are low and tools used for their corroboration are often not well characterized, their physiological relevance remains largely elusive. Antibodies targeting modified nucleotides are often used but have limitations such as low affinity or specificity. Moreover, they are not always well characterized and due to the low abundance of the modification, particularly on mRNAs, generated data sets might resemble noise rather than specific modification patterns. Therefore, it is critical that the affinity and specificity is rigorously tested using complementary approaches. Here, we provide an experimental toolbox that allows for testing antibody performance prior to their use.
format Online
Article
Text
id pubmed-7491328
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-74913282021-10-01 Validation strategies for antibodies targeting modified ribonucleotides Weichmann, Franziska Hett, Robert Schepers, Aloys Ito-Kureha, Taku Flatley, Andrew Slama, Kaouthar Hastert, Florian D. Angstman, Nicholas B. Cardoso, M. Cristina König, Julian Hüttelmaier, Stefan Dieterich, Christoph Canzar, Stefan Helm, Mark Heissmeyer, Vigo Feederle, Regina Meister, Gunter RNA Method Chemical modifications are found on almost all RNAs and affect their coding and noncoding functions. The identification of m(6)A on mRNA and its important role in gene regulation stimulated the field to investigate whether additional modifications are present on mRNAs. Indeed, modifications including m(1)A, m(5)C, m(7)G, 2′-OMe, and Ψ were detected. However, since their abundances are low and tools used for their corroboration are often not well characterized, their physiological relevance remains largely elusive. Antibodies targeting modified nucleotides are often used but have limitations such as low affinity or specificity. Moreover, they are not always well characterized and due to the low abundance of the modification, particularly on mRNAs, generated data sets might resemble noise rather than specific modification patterns. Therefore, it is critical that the affinity and specificity is rigorously tested using complementary approaches. Here, we provide an experimental toolbox that allows for testing antibody performance prior to their use. Cold Spring Harbor Laboratory Press 2020-10 /pmc/articles/PMC7491328/ /pubmed/32636310 http://dx.doi.org/10.1261/rna.076026.120 Text en © 2020 Weichmann et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Method
Weichmann, Franziska
Hett, Robert
Schepers, Aloys
Ito-Kureha, Taku
Flatley, Andrew
Slama, Kaouthar
Hastert, Florian D.
Angstman, Nicholas B.
Cardoso, M. Cristina
König, Julian
Hüttelmaier, Stefan
Dieterich, Christoph
Canzar, Stefan
Helm, Mark
Heissmeyer, Vigo
Feederle, Regina
Meister, Gunter
Validation strategies for antibodies targeting modified ribonucleotides
title Validation strategies for antibodies targeting modified ribonucleotides
title_full Validation strategies for antibodies targeting modified ribonucleotides
title_fullStr Validation strategies for antibodies targeting modified ribonucleotides
title_full_unstemmed Validation strategies for antibodies targeting modified ribonucleotides
title_short Validation strategies for antibodies targeting modified ribonucleotides
title_sort validation strategies for antibodies targeting modified ribonucleotides
topic Method
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491328/
https://www.ncbi.nlm.nih.gov/pubmed/32636310
http://dx.doi.org/10.1261/rna.076026.120
work_keys_str_mv AT weichmannfranziska validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT hettrobert validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT schepersaloys validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT itokurehataku validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT flatleyandrew validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT slamakaouthar validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT hastertfloriand validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT angstmannicholasb validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT cardosomcristina validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT konigjulian validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT huttelmaierstefan validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT dieterichchristoph validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT canzarstefan validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT helmmark validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT heissmeyervigo validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT feederleregina validationstrategiesforantibodiestargetingmodifiedribonucleotides
AT meistergunter validationstrategiesforantibodiestargetingmodifiedribonucleotides